A pioneering development in cataract surgery, spearheaded by scientists at Johns Hopkins University, promises to significantly reduce complications and improve outcomes for patients. The innovative gel, which glows under specific light, offers a promising solution to a longstanding challenge in ophthalmic procedures, with the potential to transform one of the world’s most common surgeries.
Cataracts, a condition in which the eye’s lens becomes clouded, impair vision and typically affect individuals as they age. During cataract surgery, the clouded lens is removed and replaced with an artificial one. An essential step in the procedure involves injecting a clear hydrogel to maintain eye pressure and protect the cornea. However, if the gel is not fully removed, it can lead to increased intraocular pressure, causing pain, complications, and even permanent vision loss.
Aiming to address this issue, biomedical engineering student Erick Rocher and Dr. Allen Eghrari, an associate professor of ophthalmology at the Wilmer Eye Institute, have developed a novel solution. The new hydrogel contains a fluorescent dye that changes color under blue light, turning bright green. This simple but effective color change enables surgeons to easily confirm that all gel has been removed at the end of the procedure, improving both the precision and safety of cataract surgeries and other related eye operations.
The new gel, which was featured on the cover of The Journal of Cataract & Refractive Surgery in October 2024, has already attracted attention in the medical community. Rocher and Eghrari have also filed a provisional patent for the gel, which could bring significant improvements to the way eye surgeries are performed.
“As the current hydrogel needs to remain clear for effective operation, surgeons often struggle to detect leftover gel,” said Rocher, who is the first author of the study. “Our gel provides a quick and accurate way to verify that all gel has been removed, a task that was previously much harder to accomplish.”
Previously, surgeons had tried using staining agents to make the gel visible under blue light, but these dyes sometimes leaked and spread into the eye, complicating the procedure. Rocher and Eghrari’s innovation overcomes this by chemically bonding the fluorescent dye, fluorescein, directly to the polymer forming the gel. This ensures that the gel remains clear during the surgery and only glows green under blue light, allowing surgeons to spot even the smallest traces of residual gel. The use of modern digital microscopes further enhances the visibility of the gel, without the need for a separate blue light source.
“The key advantage of this gel is its high visibility without compromising safety,” said Eghrari. “All of the components used in the gel are already proven to be safe for eye surgeries. Moreover, the addition of fluorescein does not significantly alter the gel’s viscosity, ensuring it remains familiar to surgeons.”
While preclinical testing, including trials on porcine models, has shown promising results, human trials are still necessary to fully evaluate the gel’s safety and effectiveness. The next steps involve scaling up production and optimizing dye concentrations for clinical use.
Rocher, who has been working alongside Dr. Eghrari since his freshman year, is optimistic about the gel’s future. “The potential applications for this gel are vast,” he said. “Sometimes, the simplest innovations can have the biggest impact in the medical field, and we believe this is one of those cases.”
As the team moves forward with clinical trials, the “glowing” hydrogel could become an invaluable tool in cataract surgery, enhancing surgical precision, minimizing complications, and ultimately improving patient outcomes.
Related topic:
VISTA Eye Specialist Leads in Dry Eye Treatment with Groundbreaking Study
What Are The Best Lens For Cataract Surgery?
How Long Does Eye Swelling Last After Cataract Surgery?
